This seminar will provide practical advice on the borderline issues concerning these combination products and provide key guidance on the regulatory strategy to follow.
Drug/Device and Device/Drug Combinations in the EU and USA
Apr 18th, 2018Apr 19th, 2018
Latest in Home
Studies lacking for trans breast cancer screening trends
April 25, 2024
ChatGPT-4 not reliable in cancer patient messaging
April 25, 2024